NAFLD (non-alcoholic fatty liver disease) currently affects 25% of the human population, with its prevalence on the rise. At least a quarter of this population will evolve from simple steatosis to NASH (steatohepatitis), increasing the risk of liver fibrosis and cirrhosis. Liver steatosis or...